Skip to main content
logo
Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
178.00
-1.50 (-0.84%)
At close: Sep 3, 2026

Taho Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
Market Capitalization
9,3295,7302,274--616
Market Cap Growth
16.74%151.98%---12.10%
Enterprise Value
9,0375,3432,074--430
Last Close Price
178.00111.5044.35--11.76

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
PS Ratio
4709.05681.34---49.65
PB Ratio
27.0513.524.41--3.55
P/TBV Ratio
27.1013.554.41--3.94

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
EV/Sales Ratio
-635.26---34.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
Debt / Equity Ratio
0.030.030.030.11-0.01
Net Debt / Equity Ratio
-0.84-0.89-0.93-1.01-1.15-0.74
Net Debt / EBITDA Ratio
1.221.752.851.761.841.40
Net Debt / FCF Ratio
1.421.812.891.941.670.92
Asset Turnover
0.010.02-0.01-0.05
Inventory Turnover
-----2.18
Quick Ratio
18.1915.0115.023.852.295.13
Current Ratio
18.3015.1215.093.912.395.70
Return on Equity (ROE)
-60.29%-45.62%-46.32%-80.79%--56.44%
Return on Assets (ROA)
-36.52%-27.08%-25.20%-35.89%--25.53%
Return on Capital Employed (ROCE)
-69.70%-51.20%-32.20%-54.20%-72.50%-61.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '17
Earnings Yield
-2.55%-3.74%-7.36%---22.27%
FCF Yield
-2.20%-3.65%-7.29%---22.48%
Buyback Yield / Dilution
-5.52%-13.40%-17.18%-7.73%31.26%-